Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 21, 2014; 20(31): 10876-10885
Published online Aug 21, 2014. doi: 10.3748/wjg.v20.i31.10876
Published online Aug 21, 2014. doi: 10.3748/wjg.v20.i31.10876
Figure 4 Interlukin-1β level in the colon.
Values are mean ± SEM. Significantly different from sham group at aP < 0.05; Significantly different from sham group at bP < 0.01; Significantly different from sham group at bP < 0.001; Significantly different from control group at cP < 0.05; Significantly different from control group at dP < 0.01. Significantly different from control group at dP < 0.001; Significantly different from Dexa group at eP < 0.05; Significantly different from Dexa group at fP < 0.01; Significantly different from Dexa group at fP < 0.001.
-
Citation: Moeinian M, Ghasemi-Niri SF, Mozaffari S, Abdolghaffari AH, Baeeri M, Navaea-Nigjeh M, Abdollahi M. Beneficial effect of butyrate,
Lactobacillus casei and L-carnitine combination in preference to each in experimental colitis. World J Gastroenterol 2014; 20(31): 10876-10885 - URL: https://www.wjgnet.com/1007-9327/full/v20/i31/10876.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i31.10876